A detailed history of Amundi transactions in Dexcom Inc stock. As of the latest transaction made, Amundi holds 2,202,244 shares of DXCM stock, worth $250 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
2,202,244
Previous 2,464,376 10.64%
Holding current value
$250 Million
Previous $306 Million 0.12%
% of portfolio
0.13%
Previous 0.14%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$114.22 - $140.1 $29.9 Million - $36.7 Million
-262,132 Reduced 10.64%
2,202,244 $305 Million
Q4 2023

Feb 14, 2024

SELL
$75.49 - $124.16 $8.32 Million - $13.7 Million
-110,193 Reduced 4.28%
2,464,376 $306 Million
Q3 2023

Nov 14, 2023

BUY
$86.06 - $137.93 $21.1 Million - $33.8 Million
245,207 Added 10.53%
2,574,569 $240 Million
Q2 2023

Aug 14, 2023

BUY
$112.47 - $130.98 $46.3 Million - $53.9 Million
411,442 Added 21.45%
2,329,362 $299 Million
Q1 2023

May 15, 2023

BUY
$104.0 - $122.92 $12 Million - $14.2 Million
115,337 Added 6.4%
1,917,920 $223 Million
Q4 2022

Feb 14, 2023

BUY
$84.98 - $122.67 $8.12 Million - $11.7 Million
95,594 Added 5.6%
1,802,583 $204 Million
Q3 2022

Nov 14, 2022

BUY
$76.35 - $94.18 $18.6 Million - $23 Million
243,921 Added 16.67%
1,706,989 $155 Million
Q2 2022

Aug 15, 2022

BUY
$67.99 - $132.89 $73.7 Million - $144 Million
1,084,180 Added 286.15%
1,463,068 $112 Million
Q1 2022

May 16, 2022

SELL
$94.08 - $130.2 $3.93 Million - $5.44 Million
-41,768 Reduced 9.93%
378,888 $194 Million
Q4 2021

Feb 14, 2022

BUY
$129.87 - $162.82 $3.91 Million - $4.9 Million
30,090 Added 7.7%
420,656 $192 Million
Q3 2021

Nov 15, 2021

BUY
$106.71 - $143.18 $6.69 Million - $8.97 Million
62,673 Added 19.11%
390,566 $214 Million
Q2 2021

Aug 16, 2021

BUY
$80.99 - $107.93 $26.6 Million - $35.4 Million
327,893 New
327,893 $140 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $43.8B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Amundi Portfolio

Follow Amundi and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

News

Stay updated on Amundi with notifications on news.